US Medicare set to pass on Johnson & Johnson's Charite spinal disc in 2006?
This article was originally published in Clinica
Medicare officials are raising doubts about whether they will approve a new technology add-on payment for Johnson & Johnson's Charite Artificial Disc. The disc, which was approved in October 2004 by the FDA, is intended as an alternative to spinal fusion in treating patients with back pain due to degenerative spinal discs.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.